Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.010
+0.040 (1.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Anixa Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| Market Capitalization | 101 | 136 | 113 | 98 | 172 | 143 | |
| Market Cap Growth | 17.90% | 20.70% | 14.71% | -42.82% | 20.19% | 191.52% | |
| Enterprise Value | 87 | 119 | 91 | 72 | 139 | 106 | |
| Last Close Price | 3.01 | 4.13 | 3.50 | 3.16 | 5.60 | 4.77 | |
| PS Ratio | - | - | - | 467.53 | - | 279.02 | |
| PB Ratio | 6.68 | 9.74 | 5.96 | 4.20 | 6.09 | 4.11 | |
| P/TBV Ratio | 6.69 | 8.97 | 5.63 | 4.03 | 5.91 | 4.03 | |
| EV/Sales Ratio | - | - | - | 342.38 | - | 206.32 | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.01 | -1.07 | -1.04 | -1.01 | -1.04 | -1.02 | |
| Net Debt / EBITDA Ratio | - | - | - | - | - | 2.71 | |
| Net Debt / FCF Ratio | 2.04 | 2.09 | 2.69 | 3.81 | 4.54 | 7.18 | |
| Asset Turnover | - | - | - | 0.01 | - | 0.02 | |
| Quick Ratio | 11.49 | 7.71 | 8.04 | 11.89 | 14.60 | 28.13 | |
| Current Ratio | 12.18 | 8.08 | 8.55 | 12.50 | 14.83 | 28.35 | |
| Return on Equity (ROE) | -68.06% | -67.17% | -60.10% | -38.51% | -43.74% | -61.02% | |
| Return on Assets (ROA) | -40.39% | -38.83% | -36.70% | -24.61% | -26.02% | -35.92% | |
| Return on Capital Employed (ROCE) | -78.80% | -82.90% | -72.40% | -46.90% | -48.90% | -37.50% | |
| Earnings Yield | -10.21% | -8.04% | -11.15% | -9.99% | -7.92% | -9.07% | |
| FCF Yield | -6.82% | -5.28% | -6.51% | -6.32% | -3.78% | -3.46% | |
| Buyback Yield / Dilution | -1.96% | -1.74% | -2.96% | -1.99% | -6.28% | -28.57% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.